Onyda Xr Suspension, Extended Release
Product Images NDC 24478-148

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Onyda Xr (NDC 24478-148). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nextwave Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Draw Structure (Onyda Xr Clonidine Hydrochloride Extended Release 1)

Chemical structure of clonidine hydrochloride, showing a dichlorobenzene ring connected to an imidazoline ring with chlorine atoms and associated hydrochloride (HCl).*

FDA Label Image

Figure G (Onyda Xr Clonidine Hydrochloride Extended Release 10)

An instructional illustration showing how to open a child-resistant bottle cap. The image depicts a cylindrical bottle positioned above a rectangular base. A close-up inset shows the cap with arrows indicating to push down and turn to open, accompanied by the text 'CLOSE TIGHTLY PUSH DOWN AND TURN.'*

FDA Label Image

Figure H (Onyda Xr Clonidine Hydrochloride Extended Release 11)

An illustration of an oral dosing syringe marked with volume measurements from 1 mL to 4 mL for measuring liquid medication doses.*

FDA Label Image

Figure I (Onyda Xr Clonidine Hydrochloride Extended Release 12)

An instructional illustration showing the correct method to draw liquid medication from a bottle using a syringe. The image depicts one hand holding the bottle and the other pressing the syringe plunger downward into the bottle.*

FDA Label Image

Figure J (Onyda Xr Clonidine Hydrochloride Extended Release 13)

An instructional illustration showing a hand holding a dosing syringe inserted into the opened cap of a bottle, demonstrating how to draw liquid medication from the bottle for accurate oral administration.*

FDA Label Image

Figure K (Onyda Xr Clonidine Hydrochloride Extended Release 14)

An instructional illustration showing hands administering medication using an oral dosing syringe. It demonstrates how to measure the dose by aligning the liquid level to the white end of the plunger on the syringe, with gradations marked in milliliters (mL).*

FDA Label Image

Figure L (Onyda Xr Clonidine Hydrochloride Extended Release 15)

An instructional illustration showing one hand holding a syringe and the other hand pointing at the syringe's measurement markings, likely demonstrating how to measure or administer liquid medication accurately.*

FDA Label Image

Figure M (Onyda Xr Clonidine Hydrochloride Extended Release 16)

An instructional illustration demonstrating the use of a medication bottle with a dropper or dosing device. It shows a hand holding the bottle steady while the other hand is pulling upward on the dropper, indicating how to remove it from the bottle.*

FDA Label Image

Figure N (Onyda Xr Clonidine Hydrochloride Extended Release 17)

An instructional illustration of an oral dosing syringe used for extended-release suspension. The syringe is marked with volume graduations from 1 mL to 4 mL. A large arrow points to the 2 mL mark, indicating a recommended measurement or reference volume.*

FDA Label Image

Figure O (Onyda Xr Clonidine Hydrochloride Extended Release 18)

An instructional illustration showing a child receiving an oral medication using a syringe. The syringe is inserted into the child's mouth, aimed toward the inside of the cheek, demonstrating how to administer an oral suspension.*

FDA Label Image

Figure P (Onyda Xr Clonidine Hydrochloride Extended Release 19)

A black-and-white line drawing depicting a person administering an oral medication using a syringe. The syringe is held by hand and positioned at the mouth, illustrating the method of taking an oral suspension dose.*

FDA Label Image

Figure 1 (Onyda Xr Clonidine Hydrochloride Extended Release 2)

A line graph depicting Clonidine plasma concentration (pg/mL) over time (hours) for ONYDA XR at 0.2 mg administered fed and fasted, compared to Clonidine HCl extended-release tablets, 0.1 mg fasted at 0 and 12 hours. The graph shows plasma levels peaking and then declining over 48 hours, highlighting pharmacokinetic differences between formulations and dosing conditions.*

FDA Label Image

Figure Q (Onyda Xr Clonidine Hydrochloride Extended Release 20)

An instructional illustration showing a hand gripping and twisting the cap of a bottle, indicating how to open the container for the oral suspension.*

FDA Label Image

Figure R (Onyda Xr Clonidine Hydrochloride Extended Release 21)

An instructional illustration showing a process to withdraw liquid medicine using a syringe. The left side depicts drawing liquid into the syringe from a cup, while the right side demonstrates expelling the liquid from the syringe in controlled drops.*

FDA Label Image

Onyda Label 7ml (Onyda Xr Clonidine Hydrochloride Extended Release 22)

Label for ONYDA XR 0.1 mg/mL extended-release oral suspension containing clonidine hydrochloride. The label indicates it is a 7 mL physician sample, not for sale, and is for oral use only. Manufactured by Tris Pharma, Inc. The label includes storage instructions and warns to discard the suspension 60 days after first opening.*

FDA Label Image

Onyda Carton 7ml Oral Dispenser (Onyda Xr Clonidine Hydrochloride Extended Release 23)

The image shows the carton label for ONYDA XR 0.1 mg/mL extended-release oral suspension containing clonidine hydrochloride. The 7 mL sample carton is marked "Physician Sample - Not For Sale" and labeled for oral use only. It includes storage instructions, manufacturer information (Tris Pharma, Inc), and tamper-evident warnings. The NDC is 24478-148-01.*

FDA Label Image

Onyda Label 120ml (Onyda Xr Clonidine Hydrochloride Extended Release 24)

Label for ONYDA XR (clonidine hydrochloride) extended-release oral suspension, 0.1 mg/mL strength. The prescription drug is supplied in a 120 mL bottle. The label includes usage instructions, storage conditions, tamper evidence warning, and manufacturer information for Tris Pharma, Inc. located in Monmouth Junction, NJ.*

FDA Label Image

Onyda Carton 120ml (Onyda Xr Clonidine Hydrochloride Extended Release 25)

ONYDA XR 0.1 mg/mL (clonidine hydrochloride) extended-release oral suspension packaging label. The carton shows product name, strength, dosage form, and volume of 120 mL. The label includes manufacturer information for Tris Pharma, Inc. It states the product is for oral use only, prescription use, and lists handling instructions and tamper-evident warnings. The label also mentions included dosing dispensers and bottle adapters in the carton contents.*

FDA Label Image

Figure 2 (Onyda Xr Clonidine Hydrochloride Extended Release 3)

A Kaplan-Meier survival curve displaying the estimated proportion of patients with treatment failure over time in days from randomization. The graph compares Clonidine Hydrochloride extended-release tablets (solid red line) versus placebo (dashed black line), with censored data marked by plus signs. The y-axis shows the estimated proportion of treatment failure up to 1.0, and the x-axis ranges from 0 to 220 days.*

FDA Label Image

Figure A (Onyda Xr Clonidine Hydrochloride Extended Release 4)

An instructional diagram showing the components of an oral dosing syringe and bottle adapter used for ONYDA XR suspension. Labeled parts include the bottle, oral dosing syringe with barrel, plunger, white end of plunger, and tip, along with a separate bottle adapter.*

FDA Label Image

Figure B (Onyda Xr Clonidine Hydrochloride Extended Release 5)

A black and white line drawing illustrating two hands performing a motion indicative of clapping or rubbing together. The image shows one hand from the palm side and the other from the back side, with motion lines indicating movement.*

FDA Label Image

Figure C (Onyda Xr Clonidine Hydrochloride Extended Release 6)

An instructional illustration showing how to open and close a child-resistant cap on a bottle. The image includes a close-up of the cap with arrows indicating to push down and turn to open or close. Text on the cap instructs to 'TO OPEN CLOSE TIGHTLY PUSH DOWN AND TURN.'*

FDA Label Image

Figure D (Onyda Xr Clonidine Hydrochloride Extended Release 7)

An instructional diagram showing a hand holding a bottle by its neck and depicting a bottle adapter labeled to include a rigid end and the bottle neck. This illustration appears to guide the attachment or use of the bottle adapter with the bottle.*

FDA Label Image

Figure E (Onyda Xr Clonidine Hydrochloride Extended Release 8)

An instructional illustration showing a hand grasping the cap of a small bottle, twisting it counterclockwise to open. The bottle has a narrow neck and appears designed for oral liquid medication, matching typical child-resistant packaging.*

FDA Label Image

Figure F (Onyda Xr Clonidine Hydrochloride Extended Release 9)

An instructional illustration showing a hand holding a bottle and shaking it up and down. The text on the image instructs to 'shake well up and down,' indicating proper preparation before use, likely of an oral suspension medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.